Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES Sacramento Bee DURHAM, N.C., Oct. 23, 2012 -- /PRNewswire/ -- Micell Technologies, Inc. today announced positive data from two clinical studies of its investigational MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES™), a thin-strut ... |
